AMPHENOL CORP /DE/ — fact timeline

AMPHENOL CORP /DE/ shareholders approved Advisory vote to approve compensation of named executive officers at the 2026-05-21 meeting.

“3. ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS FOR 984,297,730 AGAINST 83,096,067 ABSTAIN 5,323,917 NON-VOTES 48,665,577”

AMPHENOL CORP /DE/ shareholders approved Ratification of the selection of Deloitte & Touche LLP as independent public accountants at the 2026-05-21 meeting.

“2. RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT PUBLIC ACCOUNTANTS FOR 1,048,449,127 AGAINST 72,154,410 ABSTAIN 779,754 NON-VOTES 0”

AMPHENOL CORP /DE/ shareholders approved Election of Eight Directors at the 2026-05-21 meeting.

“are as follows: 1. ELECTION OF EIGHT DIRECTORS FOR the nominees: NOMINEE FOR AGAINST ABSTAIN NON-VOTES Nancy A. Altobello 1,060,354,260 12,136,716 226,738 48,665,577 David P. Falck 1,019,588,710 51,238,137 1,890,867 48,665,577 Sanjiv Lamba 1,061,622,681 10,849,424 245,609 48,665,577 Rita S. Lane 1,066,823,967 5,662,734 231,013 48,665,577 Robert A. Livingston 1,043,851,235 28,626,974 239,505 48,665,577 R. Adam Norwitt 1,014,364,065 58,062,011 291,638 48,665,577 Prahlad Singh 1,063,901,047 8,572,596 244,071 48,665,577 Anne Clarke Wolff 1,064,478,936 8,011,199 227,579 48,665,577”

AMPHENOL CORP /DE/ entered into Underwriting Agreement with Barclays Bank PLC, Citigroup Global Markets Limited, Commerzbank Aktiengesellschaft, HSBC Bank plc, BNP PARIBAS, J.P. Morgan Securities plc, Mizuho International plc, Standard Chartered Bank, ING Bank N.V., Belgian Branch and Siebert Williams Shank & Co., LLC valued at €600,000,000 aggregate principal amount of the Company’s 3.375% Senior Notes due 2029 and €500,000,0 (effective 2026-05-05).

“The Notes were sold in an underwritten public offering pursuant to an underwriting agreement, dated May 5, 2026, by and between the Company and Barclays Bank PLC, Citigroup Global Markets Limited, Commerzbank Aktiengesellschaft, HSBC Bank plc, BNP PARIBAS, J.P. Morgan Securities plc, Mizuho International plc, Standard Chartered Bank, ING Bank N.V., Belgian Branch and Siebert Williams Shank & Co., LLC.”

AMPHENOL CORP /DE/ incurred senior notes of €600,000,000 aggregate principal amount of the Company's 3.375% Senior Notes due 2029 and €500,000,000 aggregate princip with underwriters (Barclays Bank PLC, Citigroup Global Markets Limited, Commerzbank Aktiengesellschaft, HSBC Bank plc, BNP PARIBAS, J.P. Morgan Securities plc, Mizuho International plc, Standard Chartered Bank, ING Bank N.V., Belgian Branch and Siebert Williams Shank & Co., LLC) at 3.375% per year and 3.875% per year maturing May 12, 2029 and May 12, 2034.

“On May 12, 2026, Amphenol Corporation (the “Company”) issued and sold €600,000,000 aggregate principal amount of the Company’s 3.375% Senior Notes due 2029 (the “2029 Notes”) and €500,000,000 aggregate principal amount of the Company’s 3.875% Senior Notes due 2034 (the “2034 Notes” and, together with the 2029 Notes, the “Notes”), pursuant to the Company’s Registration Statement on Form S-3 (No. 333-293923) (the “Registration Statement”), including the related prospectus dated March 2, 2026, as supplemented by the prospectus supplement dated May 5, 2026.”

AMPHENOL CORP /DE/ entered into Underwriting Agreement with Barclays Bank PLC, Citigroup Global Markets Limited, Commerzbank Aktiengesellschaft, HSBC Bank plc, BNP PARIBAS, J.P. Morgan Securities plc, Mizuho International plc, Standard Chartered Bank, ING Bank N.V., Belgian Branch and Siebert Williams Shank & Co., LLC valued at €600 million aggregate principal amount of the Company’s 3.375% Senior Notes due 2029 and €500 milli (effective 2026-05-05).

“On May 5, 2026, Amphenol Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company and Barclays Bank PLC, Citigroup Global Markets Limited, Commerzbank Aktiengesellschaft, HSBC Bank plc, BNP PARIBAS, J.P. Morgan Securities plc, Mizuho International plc, Standard Chartered Bank, ING Bank N.V., Belgian Branch and Siebert Williams Shank & Co., LLC, relating to the offer and sale of €600 million aggregate principal amount of the Company’s 3.375% Senior Notes due 2029 (the “2029 Notes”) and €500 million aggregate principal amount of the Company’s 3.875% Senior Notes due 2034 (the “the 2034 Notes” and, together with the 2029 Notes, the “Notes”).”

AMPHENOL CORP /DE/ reported financial results for the quarter ended March 31, 2026.

“On April 29, 2026, Amphenol Corporation (the “Company”) issued a press release setting forth the Company’s financial results for the quarter ended March 31, 2026.”

AMPHENOL CORP /DE/ incurred senior notes of €500,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 3.625% maturing March 30, 2031.

“issued and sold €500,000,000 aggregate principal amount of Amphenol Technologies’ 3.625% Senior Notes due 2031”

AMPHENOL CORP /DE/ entered into Amphenol Technologies Indenture with U.S. Bank Trust Company, National Association valued at €500,000,000 aggregate principal amount (effective 2026-03-30).

“The Notes were issued pursuant to an indenture dated as of March 30, 2026 (the “Amphenol Technologies Indenture”) among Amphenol Technologies, as issuer, Amphenol Corporation, as guarantor and U.S. Bank Trust Company, National Association, as trustee”

AMPHENOL CORP /DE/ entered into Amphenol Technologies Underwriting Agreement with Barclays Bank PLC, Citigroup Global Markets Europe AG, Commerzbank Aktiengesellschaft, HSBC Bank plc, BofA Securities Europe SA, Goldman Sachs & Co. LLC, TD Global Finance unlimited company, U.S. Bancorp Investments, Inc., Loop Capital Markets LLC and Siebert Williams Shank & Co., LLC valued at €500,000,000 aggregate principal amount (effective 2026-03-24).

“On March 24, 2026, Amphenol Technologies Holding GmbH (“Amphenol Technologies”), a German limited liability company ( Gesellschaft mit beschränkter Haftung ) and wholly-owned indirect subsidiary of Amphenol Corporation (the “Company”), entered into an underwriting agreement (the “Amphenol Technologies Underwriting Agreement”) by and among Amphenol Technologies, as issuer, the Company, as guarantor, and Barclays Bank PLC, Citigroup Global Markets Europe AG, Commerzbank Aktiengesellschaft, HSBC Bank plc , BofA Securities Europe SA, Goldman Sachs & Co. LLC, TD Global Finance unlimited company, U.S. Bancorp Investments, Inc., Loop Capital Markets LLC and Siebert Williams Shank & Co., LLC, relating to the offer and sale of €500,000,000 aggregate principal amount of Amphenol Technologies’ 3.625% Senior Notes due 2031 (the “Notes”).”

AMPHENOL CORP /DE/ completed an acquisition involving CommScope Holding Company, Inc. for approximately $10.5 billion in cash (closed 2026-01-09).

“On January 9, 2026, Amphenol Corporation, a Delaware corporation (the “Company”), completed its acquisition of the Connectivity and Cable Solutions business of CommScope Holding Company, Inc., a Delaware corporation (“CommScope”), for approximately $10.5 billion in cash, subject to customary post-closing adjustments (the “Acquisition”), pursuant to the previously disclosed Purchase Agreement, dated as of August 3, 2025, by and between the Company and CommScope.”

AMPHENOL CORP /DE/ incurred senior notes of $1,000,000,000 aggregate principal amount at 4.125% maturing November 15, 2030.

“$1,000,000,000 aggregate principal amount of the Company’s 4.125% Senior Notes due 2030 (the “2030 Notes”)”

AMPHENOL CORP /DE/ incurred senior notes of $750,000,000 aggregate principal amount at 3.900% maturing November 15, 2028.

“$750,000,000 aggregate principal amount of the Company’s 3.900% Senior Notes due 2028 (the “2028 Notes”)”

AMPHENOL CORP /DE/ incurred senior notes of $750,000,000 aggregate principal amount at 3.800% maturing November 15, 2027.

“$750,000,000 aggregate principal amount of the Company’s 3.800% Senior Notes due 2027 (the “2027 Notes”)”

AMPHENOL CORP /DE/ incurred senior notes of $500,000,000 aggregate principal amount at Compounded SOFR, plus 0.53% maturing November 15, 2027.

“On November 10, 2025, Amphenol Corporation (the “Company”) issued and sold $500,000,000 aggregate principal amount of the Company’s Floating Rate Senior Notes due 2027 (the “Floating Rate Notes”)”

AMPHENOL CORP /DE/ incurred term loan of $2 billion with JPMorgan Chase Bank, N.A. and a syndicate of financial institutions at spread over either the base rate or the adjusted term SOFR maturing date that is 364 days after the funding date.

“On August 22, 2025, Amphenol Corporation (the "Company") entered into (i) a three-year, $2 billion unsecured delayed draw term loan credit agreement among the Company, certain subsidiaries of the Company, a syndicate of financial institutions and JPMorgan Chase Bank, N.A., acting as the administrative agent (the "Three-Year Delayed Draw Term Loan"), which is scheduled to mature on the three year anniversary of the funding date, and (ii) a 364-day, $2 billion unsecured delayed draw term loan credit agreement among the Company, certain subsidiaries of the Company, a syndicate of financial institutions and JPMorgan Chase Bank, N.A., acting as the administrative agent (the "364-Day Delayed Draw Term Loan"”

AMPHENOL CORP /DE/ incurred term loan of $2 billion with JPMorgan Chase Bank, N.A. and a syndicate of financial institutions at spread over either the base rate or the adjusted term SOFR maturing three year anniversary of the funding date.

“On August 22, 2025, Amphenol Corporation (the "Company") entered into (i) a three-year, $2 billion unsecured delayed draw term loan credit agreement among the Company, certain subsidiaries of the Company, a syndicate of financial institutions and JPMorgan Chase Bank, N.A., acting as the administrative agent (the "Three-Year Delayed Draw Term Loan"), which is scheduled to mature on the three year anniversary of the funding date”

AMPHENOL CORP /DE/ incurred senior notes of €600,000,000 aggregate principal amount at 3.125% maturing June 16, 2032.

“On June 16, 2025, Amphenol Corporation (the “Company”) issued and sold €600,000,000 aggregate principal amount of the Company’s 3.125% Senior Notes due 2032 (the “Notes”), pursuant to the Company’s Registration Statement on Form S-3 (No. 333-270605), including the related prospectus dated March 16, 2023, as supplemented by the prospectus supplement dated June 11, 2025.”

AMPHENOL CORP /DE/ incurred senior notes of $750,000,000 aggregate principal amount with Citigroup Global Markets Inc., Mizuho Securities USA LLC and TD Securities (USA) LLC at 4.375% maturing June 12, 2028.

“On June 12, 2025, Amphenol Corporation (the “Company”) issued and sold $750,000,000 aggregate principal amount of the Company’s 4.375% Senior Notes due 2028”

AMPHENOL CORP /DE/: Increased authorized shares of Class A Common Stock from 2 billion to 5 billion (effective 2025-05-15).

“The stockholders of Amphenol Corporation (the “Company”) approved an amendment to the Company’s Restated Certificate of Incorporation to amend Article FOURTH thereof to increase the number of shares of Class A Common Stock, par value $.001 per share (“Common Stock”), that the Company is authorized to issue by 3 billion from 2 billion to 5 billion (the “Charter Amendment”).”

Craig A. Lampo changed role as other_named_officer at AMPHENOL CORP /DE/.

“Mr. Ivas assumes the designation of principal accounting officer from Craig A. Lampo, who continues in his capacity as Chief Financial Officer and the Company’s principal financial officer.”

Michael R. Ivas was appointed as Principal Accounting Officer at AMPHENOL CORP /DE/.

“On May 8, 2025, Amphenol Corporation (the “Company”) designated Michael R. Ivas, the Company’s Vice President and Corporate Controller, as the Company’s principal accounting officer, effective as of May 8, 2025.”

AMPHENOL CORP /DE/: Amended Article SEVENTH of the Restated Certificate of Incorporation to eliminate officer liability for monetary damages for breach of fiduciary duty, consistent with new Delaware law provisions regarding officer exculpation (effective 2024-05-16).

“On May 16, 2024, the stockholders of Amphenol Corporation (the “Company”) approved an amendment to the Company’s Restated Certificate of Incorporation to amend Article SEVENTH thereof to eliminate the liability of officers for monetary damages to the Company or its stockholders for any breach of fiduciary duty, except as otherwise provided by the Delaware General Corporation Law (the “Charter Amendment”).”

AMPHENOL CORP /DE/ shareholders rejected Stockholder proposal regarding Special Shareholder Meeting Improvement at the 2024-05-16 meeting.

“6. STOCKHOLDER PROPOSAL REGARDING SPECIAL SHAREHOLDER MEETING IMPROVEMENT FOR 218,301,990 AGAINST 323,134,185 ABSTAIN 728,122 NON-VOTES 15,832,165”

AMPHENOL CORP /DE/ shareholders approved Approval of an amendment to the Company’s Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation at the 2024-05-16 meeting.

“5. APPROVAL OF AN AMENDMENT TO THE COMPANY’S RESTATED CERTIFICATE OF INCORPORATION TO REFLECT NEW DELAWARE LAW PROVISIONS REGARDING OFFICER EXCULPATION FOR 475,144,899 AGAINST 66,774,618 ABSTAIN 244,780 NON-VOTES 15,832,165”

AMPHENOL CORP /DE/ shareholders approved Advisory vote to approve compensation of named executive officers at the 2024-05-16 meeting.

“4. ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS FOR 496,901,216 AGAINST 44,975,779 ABSTAIN 287,302 NON-VOTES 15,832,165”

AMPHENOL CORP /DE/ shareholders approved Ratification of the selection of Deloitte & Touche LLP as independent public accountants at the 2024-05-16 meeting.

“3. RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT PUBLIC ACCOUNTANTS FOR 524,182,629 AGAINST 33,335,655 ABSTAIN 478,178 NON-VOTES 0”

AMPHENOL CORP /DE/ shareholders approved Ratification and approval of 2024 Restricted Stock Plan for Directors of Amphenol Corporation at the 2024-05-16 meeting.

“2. RATIFICATION AND APPROVAL OF 2024 RESTRICTED STOCK PLAN FOR DIRECTORS OF AMPHENOL CORPORATION FOR 518,310,267 AGAINST 23,612,883 ABSTAIN 241,147 NON-VOTES 15,832,165”

AMPHENOL CORP /DE/ shareholders approved Election of nine directors at the 2024-05-16 meeting.

“ELECTION OF NINE DIRECTORS FOR the nominees: NOMINEE FOR AGAINST ABSTAIN NON-VOTES Nancy A.”

AMPHENOL CORP /DE/ reported the quarter ended March 31, 2024 results: revenue Sales of $3.26 billion, EPS GAAP Diluted EPS of $0.87.

“CT 06492 Telephone (203) 265-8900 ​ ​ ​ AMPHENOL REPORTS FIRST QUARTER 2024 RESULTS AND ANNOUNCES NEW STOCK REPURCHASE PROGRAM ​ ​ First Quarter 2024 Highlights: ​ ● Sales of $3.26 billion, up 9% in U.S. dollars and 6% organically compared to the first quarter of 2023 ● GAAP Diluted EPS of $0.87, up 23% compared to prior year ● Adjusted Diluted EPS of $0.80, up 16%”

AMPHENOL CORP /DE/ incurred senior notes of $600,000,000 aggregate principal amount at 5.250% per year maturing April 5, 2034.

“$600,000,000 aggregate principal amount of the Company’s 5.250% Senior Notes due 2034”

AMPHENOL CORP /DE/ incurred senior notes of $450,000,000 aggregate principal amount at 5.050% per year maturing April 5, 2029.

“$450,000,000 aggregate principal amount of the Company’s 5.050% Senior Notes due 2029”

AMPHENOL CORP /DE/ incurred senior notes of $450,000,000 aggregate principal amount at 5.050% per year maturing April 5, 2027.

“issued and sold $450,000,000 aggregate principal amount of the Company’s 5.050% Senior Notes due 2027”

AMPHENOL CORP /DE/ entered into Indenture with U.S. Bank Trust Company, National Association, as trustee (effective 2023-03-16).

“The Notes were issued pursuant to an indenture dated as of March 16, 2023 (the “Indenture”) between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), and certain of the terms of each series of the Notes were established pursuant to an Officers’ Certificate dated April 5, 2024 (the “Officers’ Certificate”) in accordance with the Indenture.”

AMPHENOL CORP /DE/ entered into Underwriting Agreement with BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and TD Securities (USA) LLC, as representatives of the several Underwriters valued at $1,500,000,000 aggregate principal amount of Notes (effective 2024-04-02).

“The Notes were sold in an underwritten public offering pursuant to an underwriting agreement, dated April 2, 2024, by and between the Company and BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and TD Securities (USA) LLC, as representatives of the several Underwriters named in Schedule A thereto.”

AMPHENOL CORP /DE/ entered into Underwriting Agreement with BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and TD Securities (USA) LLC, as representatives of the several Underwriters named in Schedule A thereto valued at $450,000,000 aggregate principal amount of the Company’s 5.050% Senior Notes due 2027, $450,000,000 (effective 2024-04-02).

“On April 2, 2024, Amphenol Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and between the Company and BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and TD Securities (USA) LLC, as representatives of the several Underwriters named in Schedule A thereto, relating to the offer and sale of $450,000,000 aggregate principal amount of the Company’s 5.050% Senior Notes due 2027 (the “2027 Notes”), $450,000,000 aggregate principal amount of the Company’s 5.050% Senior Notes due 2029 (the “2029 Notes”) and $600,000,000 aggregate principal amount of the Company’s 5.250% Senior Notes due 2034 (the “2034 Notes” and, together with the 2027 Notes and 2029 Notes, the “Notes”).”

AMPHENOL CORP /DE/ amended Third Amended and Restated Revolving Credit Agreement with JPMorgan Chase Bank, N.A. valued at $3,000.0 million unsecured revolving commitments maturing March 2029 (effective 2024-03-21).

“On March 21, 2024, Amphenol Corporation (the “ Company ”) entered into a third amended and restated credit agreement among the Company, certain subsidiaries of the Company, as borrowers or as guarantors, a syndicate of financial institutions and JPMorgan Chase Bank, N.A., acting as administrative agent (the “ Revolving Credit Agreement ”).”

AMPHENOL CORP /DE/ reported the quarter and year ended December 31, 2023 results: revenue $3.33 billion, EPS $0.83.

“Avenue Wallingford, CT 06492 Telephone (203) 265-8900 ​ ​ ​ AMPHENOL REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS ​ ​ Fourth Quarter 2023 Highlights: ​ ● Record Sales of $3.33 billion, up 3% in U.S. dollars and down 1% organically compared to the fourth quarter of 2022 ● GAAP Diluted EPS of $0.83, up 1% compared to prior year ● Record Adjusted Diluted EPS of”

AMPHENOL CORP /DE/ reported financial results for third quarter 2023.

“On October 25, 2023, Amphenol Corporation (the "Company") issued a press release setting forth the Company's financial results for the quarter and nine months ended September 30, 2023.”

Peter J. Straub was appointed as President of the Interconnect and Sensor Systems Division at AMPHENOL CORP /DE/.

“Peter J. Straub, who currently serves as Vice President and Group General Manager of the Company’s Sensor Technology Group, will succeed Mr. Gavelle beginning January 1, 2024.”

Jean-Luc Gavelle departed as President of the Interconnect and Sensor Systems Division at AMPHENOL CORP /DE/.

“Jean-Luc Gavelle, President of the Interconnect and Sensor Systems Division of Amphenol Corporation (the “Company”), provided notice of his intent to step down from his role, effective December 31, 2023.”

AMPHENOL CORP /DE/: Adopted Fifth Amended and Restated By-Laws with amendments addressing universal proxy rules, enhancing stockholder nomination and proposal procedures, requiring director candidate interviews, and restricting proxy card color for soliciting stockholders (effective 2023-08-03).

“On August 3, 2023, the Board of Directors (the “Board”) of Amphenol Corporation (the “Company”) approved and adopted Fifth Amended and Restated By-Laws (as amended, the “By-Laws”).”

AMPHENOL CORP /DE/ reported financial results for second quarter and six months ended June 30, 2023.

“On July 26, 2023, Amphenol Corporation (the "Company") issued a press release setting forth the Company’s financial results for the quarter and six months ended June 30, 2023.”

AMPHENOL CORP /DE/ shareholders rejected Advisory vote on stockholder proposal regarding political spending disclosure at the 2023-05-18 meeting.

“5. ADVISORY VOTE ON STOCKHOLDER PROPOSAL REGARDING POLITICAL SPENDING DISCLOSURE FOR 241,656,138 AGAINST 292,896,835 ABSTAIN 3,311,841 NON-VOTES 13,686,969”

AMPHENOL CORP /DE/ shareholders approved Advisory vote on the frequency of future advisory votes to approve compensation of named executive officers at the 2023-05-18 meeting.

“4. ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS ONE YEAR 532,561,235 TWO YEARS 62,653 THREE YEARS 5,103,590 ABSTAIN 137,336 NON-VOTES 13,686,969”

AMPHENOL CORP /DE/ shareholders approved Advisory vote on compensation of named executive officers at the 2023-05-18 meeting.

“3. ADVISORY VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS FOR 484,308,525 AGAINST 53,281,794 ABSTAIN 274,495 NON-VOTES 13,686,969”

AMPHENOL CORP /DE/ shareholders approved Ratification of selection of Deloitte & Touche LLP as independent public accountants at the 2023-05-18 meeting.

“2. RATIFICATION OF SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT PUBLIC ACCOUNTANTS OF THE COMPANY FOR 522,377,765 AGAINST 28,761,906 ABSTAIN 412,112 NON-VOTES 0”

AMPHENOL CORP /DE/ shareholders approved Election of Directors at the 2023-05-18 meeting.

“1. ELECTION OF DIRECTORS FOR the nominees: NOMINEE FOR AGAINST ABSTAIN NON-VOTES Nancy A. Altobello 529,475,417 8,199,415 189,982 13,686,969 David P. Falck 491,992,999 45,671,727 200,088 13,686,969 Edward G. Jepsen 512,809,170 23,781,997 1,273,647 13,686,969 Rita S. Lane 533,019,736 4,656,169 188,909 13,686,969 Robert A. Livingston 520,881,095 16,779,299 204,420 13,686,969 Martin H. Loeffler 519,819,909 17,787,223 257,682 13,686,969 R. Adam Norwitt 535,364,371 2,303,039 197,404 13,686,969 Prahlad Singh 537,069,869 592,848 202,097 13,686,969 Anne Clarke Wolff 531,751,140 5,840,674 273,000 13,686,969”

AMPHENOL CORP /DE/ reported the quarter ended March 31, 2023 results: revenue $2.974 billion, EPS $0.71. Guidance initiated.

“● Sales of $2.974 billion, up 1% in U.S. dollars and organically compared to the first quarter of 2022 ● GAAP Diluted EPS of $0.71, up 4% compared to prior year ● Adjusted Diluted EPS of $0.69, up 3% compared to prior year ● GAAP and Adjusted Operating Margin of 19.9% and 20.1% ● Operating and Free Cash Flow of $532 million and $436 million”

AMPHENOL CORP /DE/ incurred senior notes of $350,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 4.750% per year maturing March 30, 2026.

“pursuant to Section 13(a) of the Exchange Act. ̈ Item 1.01 Entry into a Material Definitive Agreement. On March 30, 2023, Amphenol Corporation (the “Company”) issued and sold $350,000,000 aggregate principal amount of its 4.750% Senior Notes due 2026 (the “Notes”) pursuant to the Company’s Registration Statement on Form S-3 (No. 333-270605), including the related”